Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · IEX Real-Time Price · USD
3.380
-0.090 (-2.59%)
At close: Jul 2, 2024, 4:00 PM
3.460
+0.080 (2.37%)
After-hours: Jul 2, 2024, 6:04 PM EDT

Autolus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2016
Revenue
1.76.362.331.722.91
Upgrade
Revenue Growth (YoY)
-73.30%172.96%35.86%-41.02%106.68%
Upgrade
Gross Profit
1.76.362.331.722.91
Upgrade
Selling, General & Admin
46.7531.931.8734.9739.45
Upgrade
Research & Development
130.48117.35110.84134.89105.42
Upgrade
Other Operating Expenses
4.170.520.6804.1
Upgrade
Operating Expenses
181.4149.77143.38169.86148.97
Upgrade
Operating Income
-179.7-143.41-141.05-168.15-146.06
Upgrade
Interest Expense / Income
45.078.911.1100
Upgrade
Other Expense / Income
-16.37-3.75-0.12-1.89-7.06
Upgrade
Pretax Income
-208.4-148.57-142.04-166.26-139.01
Upgrade
Income Tax
-0.020.270.06-24.16-15.16
Upgrade
Net Income
-208.38-148.84-142.1-142.09-123.85
Upgrade
Shares Outstanding (Basic)
17495725243
Upgrade
Shares Outstanding (Diluted)
17495725243
Upgrade
Shares Change
83.11%31.78%39.81%19.72%36.47%
Upgrade
EPS (Basic)
-1.20-1.57-1.97-2.76-2.88
Upgrade
EPS (Diluted)
-1.20-1.57-1.97-2.76-2.88
Upgrade
Free Cash Flow
-156.57-123.15-126.72-132.44-119.83
Upgrade
Free Cash Flow Per Share
-0.90-1.30-1.76-2.57-2.78
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-10583.10%-2254.84%-6053.65%-9804.37%-5022.83%
Upgrade
Profit Margin
-12272.26%-2340.24%-6098.54%-8285.36%-4258.91%
Upgrade
Free Cash Flow Margin
-9221.02%-1936.31%-5438.54%-7722.39%-4120.53%
Upgrade
EBITDA
-152.71-128.81-128.75-160.6-134.4
Upgrade
EBITDA Margin
-8993.64%-2025.28%-5525.62%-9364.37%-4621.63%
Upgrade
Depreciation & Amortization
10.6210.8512.195.664.61
Upgrade
EBIT
-163.34-139.66-140.93-166.26-139.01
Upgrade
EBIT Margin
-9619.26%-2195.94%-6048.63%-9694.29%-4780.19%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).